SOX10 and neoplasm: In addition, 98% of tumors (49 of 50) demonstrated a lack of staining for SOX10, with the remaining tumor demonstrating focal positivity for SOX10 in less than 10% of cells; and 94% (47 of 50) demonstrated no or only focal staining for K5.